Tracking rule reminder
This article was originally published in The Gray Sheet
Joseph Levitt, the FDA device center's deputy director for regulations and policy, sends industry associations a reminder letter on FDA's tracking rule pointing out that the rule became final on Nov. 29 and will be effective Aug. 29. Levitt also informs the associations that the center is preparing a question and answer document for manufacturers that will "respond to many of the most prevalent concerns about device tracking." FDA decided to send the reminder letter because it has been slow in issuing a Federal Register notice that would formally announce the finalization of the rule and clarify some of its provisions ("The Gray Sheet" Nov. 2, p. 4).
You may also be interested in...
Last year, Mallinckrodt attempted restructuring the firm to evade bankruptcy fears. However, the company is now filing for bankruptcy for its US generics business to address “unmanageable liabilities.”
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.